Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 95
12
Diseases
17
Unique genes
0.243
Avg. similarity score
Branchial arch abnormalities syndrome
Most-connected disease (6 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Branchial arch abnormalities syndrome
Branchial cleft anomalies
kabuki syndrome 1
Choanal atresia syndrome
Vissers-bodmer syndrome
Vein of galen aneurysm
Congenital small ears
Burn-mckeown syndrome
choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome
Duane-radial ray syndrome
EPHB4-associated vascular malformation spectrum
holoprosencephaly 12 with or without pancreatic agenesis
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Branchial arch abnormalities syndrome | 6 | 6 | 1 |
| Branchial cleft anomalies | 6 | 6 | 1 |
| kabuki syndrome 1 | 6 | 6 | 1 |
| Choanal atresia syndrome | 5 | 5 | 5 |
| Vissers-bodmer syndrome | 5 | 5 | 3 |
| Vein of galen aneurysm | 4 | 4 | 6 |
| Congenital small ears | 3 | 3 | 5 |
| Burn-mckeown syndrome | 2 | 2 | 2 |
| choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome | 2 | 2 | 1 |
| Duane-radial ray syndrome | 1 | 1 | 2 |
| EPHB4-associated vascular malformation spectrum | 1 | 1 | 1 |
| holoprosencephaly 12 with or without pancreatic agenesis | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| KMT2D | 7 / 12 | Branchial arch abnormalities syndrome, Branchial cleft anomalies, Choanal atresia syndrome, Congenital small ears and 3 more |
| TXNL4A | 3 / 12 | Burn-mckeown syndrome, Choanal atresia syndrome, choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome |
| CNOT1 | 2 / 12 | holoprosencephaly 12 with or without pancreatic agenesis, Vissers-bodmer syndrome |
| EPHB4 | 2 / 12 | EPHB4-associated vascular malformation spectrum, Vein of galen aneurysm |
| IPO8 | 2 / 12 | Duane-radial ray syndrome, Vissers-bodmer syndrome |
| POLR1A | 2 / 12 | Burn-mckeown syndrome, Choanal atresia syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Breakdown of the nuclear lamina | Reactome | 1 / 3 | 235× | 4.24e-3 | 3.93e-2 ✓ sig. |
| Nuclear Envelope Breakdown | Reactome | 1 / 9 | 78.5× | 1.27e-2 | 7.87e-2 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | Reactome | 1 / 10 | 70.6× | 1.41e-2 | 8.38e-2 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | Reactome | 1 / 13 | 54.3× | 1.83e-2 | 9.79e-2 |
| Sema3A PAK dependent Axon repulsion | Reactome | 1 / 15 | 47.1× | 2.10e-2 | 1.06e-1 |
| Depolymerisation of the Nuclear Lamina | Reactome | 1 / 15 | 47.1× | 2.10e-2 | 1.06e-1 |
| CRMPs in Sema3A signaling | Reactome | 1 / 16 | 44.2× | 2.24e-2 | 1.10e-1 |
| Transcriptional regulation of pluripotent stem cells | Reactome | 1 / 17 | 41.6× | 2.38e-2 | 1.13e-1 |
| Ephrin signaling | Reactome | 1 / 19 | 37.2× | 2.66e-2 | 1.21e-1 |
| Initiation of Nuclear Envelope (NE) Reformation | Reactome | 1 / 19 | 37.2× | 2.66e-2 | 1.21e-1 |
| Axon guidance | KEGG | 2 / 183 | 7.7× | 2.70e-2 | 1.22e-1 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | Reactome | 1 / 20 | 35.3× | 2.80e-2 | 1.24e-1 |
| Interleukin-37 signaling | Reactome | 1 / 21 | 33.6× | 2.93e-2 | 1.27e-1 |
| EPH-Ephrin signaling | Reactome | 1 / 22 | 32.1× | 3.07e-2 | 1.31e-1 |
| Regulation of TP53 Activity through Acetylation | Reactome | 1 / 23 | 30.7× | 3.21e-2 | 1.34e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| heterochromatin formation | GO:0031507 | 3 / 70 | 47.1× | 3.30e-5 | 1.31e-3 ✓ sig. |
| cardiac septum morphogenesis | GO:0060411 | 2 / 16 | 137× | 9.28e-5 | 2.86e-3 ✓ sig. |
| pharyngeal system development | GO:0060037 | 2 / 21 | 105× | 1.62e-4 | 4.34e-3 ✓ sig. |
| motor neuron axon guidance | GO:0008045 | 2 / 24 | 91.6× | 2.12e-4 | 5.27e-3 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 6 / 1,208 | 5.5× | 4.80e-4 | 9.31e-3 ✓ sig. |
| negative regulation of cell population proliferation | GO:0008285 | 4 / 444 | 9.9× | 5.85e-4 | 1.07e-2 ✓ sig. |
| beta-catenin-TCF complex assembly | GO:1904837 | 1 / 1 | 1,099× | 9.10e-4 | 1.42e-2 ✓ sig. |
| right ventricular compact myocardium morphogenesis | GO:0003226 | 1 / 1 | 1,099× | 9.10e-4 | 1.42e-2 ✓ sig. |
| rhombomere 3 morphogenesis | GO:0021658 | 1 / 1 | 1,099× | 9.10e-4 | 1.42e-2 ✓ sig. |
| tissue development | GO:0009888 | 2 / 51 | 43.1× | 9.67e-4 | 1.47e-2 ✓ sig. |
| cellular senescence | GO:0090398 | 2 / 57 | 38.6× | 1.21e-3 | 1.70e-2 ✓ sig. |
| pattern specification process | GO:0007389 | 2 / 60 | 36.6× | 1.34e-3 | 1.79e-2 ✓ sig. |
| heart morphogenesis | GO:0003007 | 2 / 61 | 36.0× | 1.38e-3 | 1.84e-2 ✓ sig. |
| negative regulation of protein localization to nucleolus | GO:1904750 | 1 / 2 | 550× | 1.82e-3 | 2.15e-2 ✓ sig. |
| rhombomere 2 development | GO:0021568 | 1 / 2 | 550× | 1.82e-3 | 2.15e-2 ✓ sig. |